🔗 Share this article

Given that the US proceeds with sweeping revisions to its vaccination schedules, a particular individual has emerged unexpectedly: Dr. Tracy Beth Høeg, a Danish American sports medicine doctor and epidemiologist who initially gained attention by casting doubt on Covid vaccines throughout the global health crisis and has zeroed in on potential fatalities following COVID-19 immunization in her short position at the US Food and Drug Administration (FDA).

Scheduled Overhauls to Childhood Immunization Schedule

Public health authorities were set to reveal sweeping changes to the pediatric vaccination calendar recently, bringing the US with the Danish national calendar, according to reports – a substantial departure that would put the US out of step with a large portion of the international standard with insufficient data for improved outcomes. The planned update has been postponed until the next year.

Instead of Vinay Prasad, Tracy Beth Høeg is set to address the audience at the meeting. She was just designated acting director of the FDA’s CDER, the fifth individual to run the center this year.

A New Direction at the FDA

Høeg's temporary position could signify a tighter collaboration between the drug and vaccine branches as Høeg and Prasad strengthen their influence at the agency – and it suggests a renewed priority upon dismantling already-approved immunizations at the FDA.

Høeg has frequently advocated for discontinuing specific childhood immunization guidelines in the US to become more like Denmark, a nation with universal health coverage and a citizenry approximately the size of the state of Wisconsin.

In her initial comments, she has continued to focus on vaccines – usually the domain of Prasad, head of the FDA’s CBER – rather than drug regulation.

Doubts Over Background

The appointee has little discernible track record in pharmaceutical research, oversight or administrative roles, which has been typical for former leaders of the biologics center. She has worked at the FDA as a key advisor to the agency head and the vaccine center since March.

“She appears not to have the necessary background” for leading the drug-regulation department, stated Jonathan Howard. “She has not conducted a scientific study. She has no expertise in leading a large organization. She has no expertise in industry regulation.”

Past commissioners of the center would “grasp regulatory frameworks and the science of drug development”, noted Janet Woodcock. “Frankly, she doesn’t have the kind of background that previous people who headed CBER have had.”

The drug center has an vast portfolio at the FDA, the former commissioner pointed out.

“The public just zeroes in on the innovative therapies, but the off-patent medication office authorizes thousands of off-brand pharmaceuticals. There is also a biosimilars program, non-prescription drug unit and other areas, and each of these must be looked after,” Dr. Woodcock said. “The responsibility you neglect, that is precisely what that I always told people is going to come back to haunt you.”

Additionally, a significant administrative element to the job, which manages more than 5,000 personnel. “It is a massive management job, if you do it right,” Woodcock concluded.

Official Statement and Disputed Initiatives

When asked about concerns about Dr. Høeg's fitness for the role and whether this assignment signifies more teamwork among FDA leaders on vaccines, a press secretary responded that the “inquiries rely on flawed assumptions”.

“Her resume matches the duties of her position,” the official explained, noting the time Dr. Høeg spent guiding the FDA commissioner on “pharmaceutical safety and oversight research, including computerized risk analysis and immunization monitoring”.

As acting director, Høeg takes over the agency head's recently launched expedited review system, a disputed expedited therapy clearance system that reportedly troubled her preceding directors. “By what process are these medications being picked for this fast-track system? Who is making the decisions?” Howard asked. “There’s a lot of confidentiality happening at the FDA right now.”

Overall, he stated, “the FDA seems to be moving towards laxer regulations of pharmaceuticals, except for shots.”

Established Track Record on Vaccines

With immunizations, Høeg has a more established, if concerning, track record, some experts observe. She published a study using unverified crowd-sourced reports to assess the incidence of myocarditis following Covid vaccination. She counseled the Florida chief medical officer Dr. Joseph Ladapo, who was said to have altered data to imply Covid vaccinations are riskier than they are.

Among her “desired changes” for the current administration featured revising guidelines for novel immunizations and halting “unnecessary” vaccines, she stated post-election on a audio program. At the agency, Høeg has reportedly proposed preventing adolescent males from getting COVID-19 vaccinations.

“She’s an thorough true believer who commences with her preconceived notions and works backwards to retrofit the science in a extremely misleading, fraudulent manner,” Dr. Howard argued.

Gaining Influence and a “Campaign of Retribution”

Høeg joined fellow skeptics, {like|